Wednesday, June 10, 2026

pharma Β· Type 2 Diabetes Mellitus Β· Irritable Bowel Syndrome Β· LXRX

LEXICON PHARMACEUTICALS

LEXICON PHARMACEUTICALS clinical programs β€” 51 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

8800 Technology Forest, The Woodlands, TX 77381, US HQ
1995 Founded
282 Employees
Public company Type
LXRX Β· NYSE Ticker
Company details
Status
Public
HQ
8800 Technology Forest, The Woodlands, TX 77381, US
Founded
1995
Employees
282
Programs
51
Drugs
27
Patents
102
Intelligence Β· Clinical Programs

LEXICON PHARMACEUTICALS projects

51 ClinicalTrials.gov programs sponsored by LEXICON PHARMACEUTICALS.

LEXICON PHARMACEUTICALS has 51 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

Page 2 of 2
  1. [14C]-LX4211

    LEXICON PHARMACEUTICALS, INC.

    Healthy

    phase 1 small molecule completed

    1 trial
  2. sotagliflozin

    LEXICON PHARMACEUTICALS, INC.

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial
  3. sotagliflozin

    LEXICON PHARMACEUTICALS, INC.

    Healthy

    phase 1 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does LEXICON PHARMACEUTICALS have?

51 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.